Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arlene B Chapman

Showing results (11-20 of 220) with videos related to

Pageof 22
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 5, 2003
Cystic and inherited kidney diseasesDana Rizk, Arlene B Chapman
Kidney360|April 14, 2022
Polycystic Kidney Disease in the Real WorldArlene B Chapman, Rita McGill
Nature Reviews. Nephrology|October 10, 2017
New treatment paradigms for ADPKD: moving towards precision medicineMatthew B Lanktree, Arlene B Chapman
Pharmacogenomics|February 28, 2019
The future of pharmacogenetics in the treatment of hypertensionPatrick N Cunningham, Arlene B Chapman
Clinical Journal of the American Society of Nephrology : CJASN|June 13, 2025
KDIGO 2025 ADPKD Guidelines: Real-World Perspectives on Nomenclature, Tolvaptan Use and Polycystic Liver DiseaseBharathi V Reddy, Arlene B Chapman
Kidney International Reports|April 11, 2020
Polycystins, ADPKD, and Cardiovascular DiseaseIvana Y Kuo, Arlene B Chapman
Clinical Journal of the American Society of Nephrology : CJASN|August 9, 2017
A Patient with a Novel Gene Mutation Leading to Autosomal Dominant Polycystic Kidney DiseaseBharathi V Reddy, Arlene B Chapman
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 15, 2017
Autosomal dominant polycystic kidney diseaseMatthew B Lanktree, Arlene B Chapman
Advances in Chronic Kidney Disease|March 17, 2016
A Physiologic Approach to the Pharmacogenomics of HypertensionMichael T Eadon, Arlene B Chapman
Pediatric Nephrology (Berlin, Germany)|April 2, 2016
The spectrum of autosomal dominant polycystic kidney disease in children and adolescentsBharathi V Reddy, Arlene B Chapman
Pageof 22

Showing results (11-20 of 220) with videos related to

Sort By:
Pageof 22
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 5, 2003
Cystic and inherited kidney diseasesDana Rizk, Arlene B Chapman
Kidney360|April 14, 2022
Polycystic Kidney Disease in the Real WorldArlene B Chapman, Rita McGill
Nature Reviews. Nephrology|October 10, 2017
New treatment paradigms for ADPKD: moving towards precision medicineMatthew B Lanktree, Arlene B Chapman
Pharmacogenomics|February 28, 2019
The future of pharmacogenetics in the treatment of hypertensionPatrick N Cunningham, Arlene B Chapman
Clinical Journal of the American Society of Nephrology : CJASN|June 13, 2025
KDIGO 2025 ADPKD Guidelines: Real-World Perspectives on Nomenclature, Tolvaptan Use and Polycystic Liver DiseaseBharathi V Reddy, Arlene B Chapman
Kidney International Reports|April 11, 2020
Polycystins, ADPKD, and Cardiovascular DiseaseIvana Y Kuo, Arlene B Chapman
Clinical Journal of the American Society of Nephrology : CJASN|August 9, 2017
A Patient with a Novel Gene Mutation Leading to Autosomal Dominant Polycystic Kidney DiseaseBharathi V Reddy, Arlene B Chapman
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 15, 2017
Autosomal dominant polycystic kidney diseaseMatthew B Lanktree, Arlene B Chapman
Advances in Chronic Kidney Disease|March 17, 2016
A Physiologic Approach to the Pharmacogenomics of HypertensionMichael T Eadon, Arlene B Chapman
Pediatric Nephrology (Berlin, Germany)|April 2, 2016
The spectrum of autosomal dominant polycystic kidney disease in children and adolescentsBharathi V Reddy, Arlene B Chapman
Pageof 22